Navigation Links
Recombinant C-Reactive Protein
Date:5/7/2009

ST. LOUIS, May 7 /PRNewswire/ -- Lee Biosolutions has announced that it will increase its C-Reactive Protein product line to include recombinant C-Reactive Protein.

C-Reactive Protein is a protein found in the blood that operates as a marker for inflammation, meaning its presence indicates an increased state of inflammation in the body. Inflammation is a normal response to a number of physical states including injury, fever and infection. Inflammation is also believed to play a role in the initiation and progression of cardiovascular disease.

r-hCRP is produced into culture medium by DNA recombinant procedure in E. Coli as secretory protein. By expressing kil gene, the outer membrane of E. Coli becomes permeable, allowing recombinant C-Reactive Protein to be excreted without cell lysis. r-hCRP has similar biological property in terms of Ca2+-binding ability to the native protein, and is purified by affinity chromatography. N-terminal amino acid sequence of r-hCRP is the same as that of the native human c-reactive protein.

According to Lee Biosolutions President Burton Lee, the company pays close

attention to the clinical research community to stay ahead of their demands for acute phase proteins like C-Reactive Protein CRP . Lee Biosolution now has canine, rat, human and recombinant c-reactive protein.

    Press Release Contact Information:
    Burton Lee
    President
    Lee Biosolutions, Inc
    314-968-1091
    info@leebio.com
    www.leebio.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.


'/>"/>
SOURCE Lee Biosolutions, Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
2. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
3. New Recombinant XYNTHA Now Available for Patients with Hemophilia A
4. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
5. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
6. Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies
7. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Recombinant Human Renin - Crystallographic Grade
10. Protein Sciences Announces Signing of a Forbearance Agreement With Emergent BioSolutions
11. Xennex Inc. Providing Satoris Inc. with Latest GeneCards(R) Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine ... and immunotherapy company, today announced that the U.S. ... for Fast Track designation and Phase I clinical ... conjunction with the mutual co-development agreement signed with ... Fast Track designation for the DPX-Survivac. , “We ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Cytokinetics, Incorporated ... on February 28 with patients and health care advocates ... for Rare Disease Day®. Rare Disease Day is ... calling attention to the special challenges faced by patients ... , “Cytokinetics is proud to stand alongside patients and ...
(Date:2/26/2015)... Feb. 26, 2015  23andMe, the leading personal genetics ... as Privacy Officer and Corporate Counsel. Black brings ... laws as well as health care regulations. As a ... be responsible for reviewing, updating and enhancing the company,s ... and abroad. She joined the company January 5, 2015 ...
(Date:2/26/2015)... LAUDERDALE, Fla. , Feb. 26, 2015 ... discussed growth priorities driven by key research advancements and ... segments at today,s Bank of America Merrill Lynch 2015 ... met the challenge of building grain supplies the last ... to continue at the pace of the last decade, ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... parameter at the upcoming World ... Congress of Anesthesiologists Meeting, IRVINE, ... and Measure-Through Motion and Low Perfusion pulse,oximetry, announced that ... total hemoglobin (SpHb(TM)) and oxygen content,(SpOC(TM)) monitoring at the ...
... 25 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... first Phase 3 clinical trial with AZ-004 ... being developed for the treatment of,acute agitation ... Alexza,believes the novel, non-invasive nature and rapid ...
... Germany, February 25 t2cure, a clinical,stage biopharmaceutical ... cells, announced today that it has appointed,Dr. Petra ... pleased to have Petra join our company", said ... research and project,management will be of critical importance ...
Cached Biology Technology:Masimo Announces Continuous Noninvasive Total Hemoglobin 2Masimo Announces Continuous Noninvasive Total Hemoglobin 3Masimo Announces Continuous Noninvasive Total Hemoglobin 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations 2
(Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
(Date:2/5/2015)... VIEW, Calif. , Feb. 3, 2015 /PRNewswire/ ... printer technology, demand from industries such as consumer ... global market for surface mount technology (SMT) screen ... equipment to automatic control will push the adoption ... dispensers will remain steady as glue dispensers are ...
(Date:1/22/2015)... MELBOURNE, Fla. , Jan. 13, 2015  Today, ... wearable technology, launched its crowdfunding campaign on Fundable, ... accelerate the build of production capacity to meet ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
Breaking Biology News(10 mins):IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2
... - The growth in China,s carbon dioxide (CO2) emissions ... stabilizing atmospheric greenhouse gases even more difficult, according to ... California, Berkeley, and UC San Diego. Previous estimates, ... Change, say the region that includes China will see ...
... Research Prize and Medal will be awarded to Philip R. ... of Overseers and NJIT President Robert A. Altenkirch on March ... Solar-Terrestrial Research which has led a five-year project to build ... Observatory (BBSO), Big Bear Lake, CA. First light ...
... was not geographically isolated 25 million years ago ... demonstrated by researchers from the Laboratoire des Mcanismes ... Toulouse 3/IRD) and the Palobiodiversit et paloenvironnements laboratory ... results were obtained thanks to analyses of the ...
Cached Biology News:Alarming growth in expected CO2 emissions in China, finds UC analysis 2Alarming growth in expected CO2 emissions in China, finds UC analysis 3NJIT overseers to award NJIT physicist new medal and prize 2A fossilized giant rhino bone questions the isolation of Anatolia, 25 million years ago 2
... PRODUCT SPECIFICATIONS Form: White powder Assay: 1.5 - 2.0 Bleomycin ... 6.0 Loss On Drying: less than or equal to 6.0% ... A 2 : 55 - 70% B 2 : 25 ... or equal to 90% B 4 : less than or ...
... High Vacuum pumps deliver critical performance for ... ballast control optimizes pump performance to suit ... allows for convenient checking of proper oil ... of pumps is designed to work with ...
6 x Blend of rTth DNA Polymerase and Tli to provide optimized amounts of both 5-3 and 3-5 proofreading activity...
This spacer is required to use the Miniature FRENCH Pressure Cell (FA-003) with the Laboratory Press....
Biology Products: